======= GTPBP4 ======= == Gene Information == * **Official Symbol**: GTPBP4 * **Official Name**: GTP binding protein 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23560|23560]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BZE4|Q9BZE4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GTPBP4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GTPBP4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619169|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in the biogenesis of the 60S ribosomal subunit. {ECO:0000250}. |NOGCT| |Miro| |FeoB N| |MMR HSR1| |NOG1| |negative regulation of collagen binding| |regulation of collagen binding| |maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)| |maturation of LSU-rRNA| |negative regulation of DNA replication| |ribosomal large subunit biogenesis| |negative regulation of protein ubiquitination| |negative regulation of protein modification by small protein conjugation or removal| |regulation of cyclin-dependent protein serine/threonine kinase activity| |regulation of cyclin-dependent protein kinase activity| |regulation of DNA replication| |osteoblast differentiation| |negative regulation of binding| |negative regulation of cell-cell adhesion| |protein stabilization| |regulation of protein ubiquitination| |rRNA processing| |rRNA metabolic process| |regulation of protein modification by small protein conjugation or removal| |nuclear membrane| |negative regulation of cell migration| |ossification| |negative regulation of cell adhesion| |negative regulation of cell motility| |regulation of protein stability| |ribosome biogenesis| |negative regulation of cellular component movement| |negative regulation of locomotion| |GTPase activity| |regulation of binding| |ncRNA processing| |GTP binding| |regulation of cell-cell adhesion| |ribonucleoprotein complex biogenesis| |ncRNA metabolic process| |regulation of protein serine/threonine kinase activity| |negative regulation of protein modification process| |negative regulation of cell population proliferation| |regulation of cell adhesion| |perinuclear region of cytoplasm| |regulation of protein kinase activity| |regulation of cell migration| |nucleolus| |regulation of kinase activity| |RNA processing| |regulation of cell motility| |regulation of transferase activity| |regulation of locomotion| |Golgi apparatus| |regulation of cellular component movement| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |regulation of phosphorylation| |regulation of cell population proliferation| |RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-2.8| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.38| |[[:results:exp90|WYE-354 6μM R02 exp90]]|-2.02| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.87| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.86| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-1.84| |[[:results:exp133|MKC9989 10μM R03 exp133]]|-1.77| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.81| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.84| |[[:results:exp482|Fas-L 44ng/ml R08 exp482]]|2.13| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.16| |[[:results:exp453|B02 10μM R08 exp453]]|2.19| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.19| |[[:results:exp303|39°C R06 exp303]]|2.35| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|2.57| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.439| |[[:human genes:g:golga6l1|GOLGA6L1]]|0.408| Global Fraction of Cell Lines Where Essential: 684/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|25/28| |blood|25/28| |bone|25/26| |breast|28/33| |central nervous system|52/56| |cervix|4/4| |colorectal|14/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|19/21| |liver|19/20| |lung|70/75| |lymphocyte|14/16| |ovary|24/26| |pancreas|23/24| |peripheral nervous system|14/16| |plasma cell|15/15| |prostate|1/1| |skin|23/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|19/22| |urinary tract|26/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 627 * **Expression level (log2 read counts)**: 7.43 {{:chemogenomics:nalm6 dist.png?nolink |}}